Matthew Gline's Net Worth
Matthew Gline's net worth is estimated to be at least $25,603,335.30 as of 12/24/2024. CoreStreet's estimation of Matthew Gline's net worth is based on their sale of stock and current holding of stock.
Matthew Gline is CEO at Roivant Sciences Ltd. They have executed at least 12 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,983,257 units of ROIV stock on 09/23/2024. Their biggest sale was on 09/23/2024 when they sold 1,983,257 units of Roivant Sciences Ltd stock for $23,382,600.03. They typically trade 6 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $25,603,335.30
Most recent insider trade:
- Sept. 23, 2024
Matthew Gline's Insider Trading History
| Roivant Sciences Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 23, 2024 | CEO | 1,983,257 | $11.79 | Sell | $23,382,600.03 |
Oct. 25, 2022 | CEO | 19,276 | $4.40 | Sell | $84,814.40 |
Sept. 23, 2022 | CEO | 21,053 | $3.07 | Sell | $64,632.71 |
Aug. 24, 2022 | CEO | 20,009 | $3.71 | Sell | $74,233.39 |
July 25, 2022 | CEO | 20,455 | $4.33 | Sell | $88,570.15 |
June 23, 2022 | CEO | 19,855 | $4.34 | Sell | $86,170.70 |
May 20, 2022 | CEO | 139,791 | $3.70 | Sell | $517,226.70 |
April 25, 2022 | CEO | 8,509 | $3.84 | Sell | $32,674.56 |
March 30, 2022 | CEO | 33,686 | $4.84 | Sell | $163,040.24 |
March 25, 2022 | CEO | 35,386 | $5.06 | Sell | $179,053.16 |
March 18, 2022 | CEO | 82,006 | $5.13 | Sell | $420,690.78 |
March 7, 2022 | CEO | 92,324 | $5.52 | Sell | $509,628.48 |